The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Walker Luke Nathaniel since 2018.
This trader's CIK number is 1701440.
At the time of last reporting, Walker Luke Nathaniel was the Director of Zentalis Pharmaceuticals, Inc.. (stock ticker symbol ZNTL).
Also see all insider trading activities at Zentalis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | CASC | 0 | $0 | 0 | $0 | 1,950 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ZNTL | 14,200 | $24,963 | 0 | $0 | 0 | $0 |
1. Cascadian Therapeutics, Inc. (CASC)
2. Zentalis Pharmaceuticals, Inc. (ZNTL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-11 | CASC | Option Ex | 1,950 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-31 | ZNTL | Buy | 14,200 | 1.76 | 24,963 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Walker Luke Nathaniel (Director of Zentalis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.